Page 165 - Williams Hematology ( PDFDrive )

140 Part III: Epochal Hematology Chapter 9: Hematology in Older Persons 141

200. Lugada ES, Mermin J, Kaharuza F, et al: Population-based hematologic and immu- 230. Tofler GH, Massaro J, Levy D, et al: Relation of the prothrombotic state to increasing
nologic reference values for a healthy Ugandan population. Clin Diagn Lab Immunol age (from the Framingham Offspring Study). Am J Cardiol 96(9):1280–1283, 2005.
11(1):29–34, 2004. 231. Cushman M, Yanez D, Psaty BM, et al: Association of fibrinogen and coagulation
201. Nilsson-Ehle H, Jagenburg R, Landahl S, et al: Haematological abnormalities and refer- factors VII and VIII with cardiovascular risk factors in the elderly: The Cardiovascu-
ence intervals in the elderly. A cross-sectional comparative study of three urban Swed- lar Health Study. Cardiovascular Health Study Investigators. Am J Epidemiol 143(7):
ish population samples aged 70, 75 and 81 years. Acta Med Scand 224(6):595–604, 1988. 665–676, 1996.
202. Lee SJ, Lindquist K, Segal MR, Covinsky KE: Development and validation of a prognos- 232. Tracy RP, Arnold AM, Ettinger W, et al: The relationship of fibrinogen and factors VII
tic index for 4-year mortality in older adults. JAMA 295(7):801–808, 2006. and VIII to incident cardiovascular disease and death in the elderly: Results from the
203. Takubo T, Tatsumi N. [Reference values for hematologic laboratory tests and hemato- cardiovascular health study. Arterioscler Thromb Vasc Biol 19(7):1776–1783, 1999.
logic disorders in the aged] [in Japanese]. Rinsho Byori 48(3):207–216, 2000. 233. Cohen HJ, Harris T, Pieper CF: Coagulation and activation of inflammatory path-
204. Haverkate F, Thompson SG, Duckert F: Haemostasis factors in angina pectoris; relation ways in the development of functional decline and mortality in the elderly. Am J Med
to gender, age and acute-phase reaction. Results of the ECAT Angina Pectoris Study 114(3):180–187, 2003.
Group. Thromb Haemost 73(4):561–567, 1995. 234. McDermott MM, Greenland P, Green D, et al: D-dimer, inflammatory markers, and
205. Kario K, Matsuo T, Kobayashi H: Close relationship between hemostatic factors lower extremity functioning in patients with and without peripheral arterial disease.
and acute-phase reaction as normal aging process. J Am Geriatr Soc 44(5):614–615, Circulation 107(25):3191–3198, 2003.
1996. 235. Wilson CJ, Cohen HJ, Pieper CF: Cross-linked fibrin degradation products (D-dimer),
206. Mari D, Mannucci PM, Coppola R, et al: Hypercoagulability in centenarians: The para- plasma cytokines, and cognitive decline in community-dwelling elderly persons. J Am
dox of successful aging. Blood 85(11):3144–3149, 1995. Geriatr Soc 51(10):1374–1381, 2003.
207. Scarabin PY, Van Dreden P, Bonithon-Kop C, et al: Age-related changes in factor VII 236. Rafnsson SB, Deary IJ, Smith FB, et al: Cognitive decline and markers of inflammation
activation in healthy women. Clin Sci (Lond) 75(4):341–343, 1988. and hemostasis: The Edinburgh Artery Study. J Am Geriatr Soc 55(5):700–707, 2007.
208. Balleisen L, Bailey J, Epping PH, et al: Epidemiological study on factor VII, factor 237. McDermott MM, Ferrucci L, Liu K, et al: D-dimer and inflammatory markers as pre-
VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, dictors of functional decline in men and women with and without peripheral arterial
gender, body-weight, smoking, alcohol, pill-using, and menopause. Thromb Haemost disease. J Am Geriatr Soc 53(10):1688–1696, 2005.
54(2):475–479, 1985. 238. Yamamoto K, Shimokawa T, Yi H, et al: Aging and obesity augment the stress-induced
209. Conlan MG, Folsom AR, Finch A, et al: Associations of factor VIII and von Willebrand expression of tissue factor gene in the mouse. Blood 100(12):4011–4018, 2002.
factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk 239. Kop WJ, Gottdiener JS, Tangen CM, et al: Inflammation and coagulation factors in per-
in Communities (ARIC) Study. Thromb Haemost 70(3):380–385, 1993. sons > 65 years of age with symptoms of depression but without evidence of myocardial
210. Ernst E, Resch KL: Fibrinogen as a cardiovascular risk factor: A meta-analysis and ischemia. Am J Cardiol 89(4):419–424, 2002.
review of the literature. Ann Intern Med 118(12):956–963, 1993. 240. Panagiotakos DB, Pitsavos C, Chrysohoou C, et al: Inflammation, coagulation, and
211. Cadroy Y, Daviaud P, Saivin S, et al: Distribution of 16 hemostatic laboratory variables depressive symptomatology in cardiovascular disease-free people; the ATTICA study.
assayed in 100 blood donors. Nouv Rev Fr Hematol 32(4):259–264, 1990. Eur Heart J 25(6):492–499, 2004.
212. Gudnason T, Hrafnkelsdottir T, Wall U, et al: Fibrinolytic capacity increases with age 241. von Kanel R, Dimsdale JE, Mills PJ, et al: Effect of Alzheimer caregiving stress and age
in healthy humans, while endothelium-dependent vasodilation is unaffected. Thromb on frailty markers interleukin-6, C-reactive protein, and D-dimer. J Gerontol A Biol Sci
Haemost 89(2):374–381, 2003. Med Sci 61(9):963–969, 2006.
213. Sundell IB, Nilsson TK, Ranby M, et al: Fibrinolytic variables are related to age, sex, 242. von Kanel R, Mills PJ, Fainman C, Dimsdale JE: Effects of psychological stress and
blood pressure, and body build measurements: A cross-sectional study in Norsjo, psychiatric disorders on blood coagulation and fibrinolysis: A biobehavioral pathway
Sweden. J Clin Epidemiol 42(8):719–723, 1989. to coronary artery disease? Psychosom Med 63(4):531–544, 2001.
214. Dolan G, Neal K, Cooper P, et al: Protein C, antithrombin III and plasminogen: Effect 243. Walston J, McBurnie MA, Newman A, et al: Frailty and activation of the inflammation
of age, sex and blood group. Br J Haematol 86(4):798–803, 1994. and coagulation systems with and without clinical comorbidities: Results from the Car-
215. Pieper CF, Rao KM, Currie MS, et al: Age, functional status, and racial differences in diovascular Health Study. Arch Intern Med 162(20):2333–2341, 2002.
plasma D-dimer levels in community-dwelling elderly persons. J Gerontol A Biol Sci 244. Folsom AR, Boland LL, Cushman M, et al: Frailty and risk of venous thromboembolism
Med Sci 55(11):M649–M657, 2000. in older adults. J Gerontol A Biol Sci Med Sci 62(1):79–82, 2007.
216. Juhan-Vague I, Renucci JF, Grimaux M, et al: Thrombin-activatable fibrinolysis 245. Chinn IK, Blackburn CC, Manley NR, Sempowski GD: Changes in primary lymphoid
inhibitor antigen levels and cardiovascular risk factors. Arterioscler Thromb Vasc Biol organs with aging. Semin Immunol 24(5):309–320, 2012.
20(9):2156–2161, 2000. 246. Aspinall R: Longevity and the immune response. Biogerontology 1(3):273–278, 2000.
217. Schatteman KA, Goossens FJ, Scharpe SS, et al: Assay of procarboxypeptidase U, a novel 247. Tyan ML: Age-related decrease in mouse T cell progenitors. J Immunol 118(3):846–851,
determinant of the fibrinolytic cascade, in human plasma. Clin Chem 45(6 Pt 1):807–813, 1977.
1999. 248. Aspinall R: Age-associated thymic atrophy in the mouse is due to a deficiency affect-
218. Mehta J, Mehta P, Lawson D, Saldeen T: Plasma tissue plasminogen activator inhibitor ing rearrangement of the TCR during intrathymic T cell development. J Immunol
levels in coronary artery disease: Correlation with age and serum triglyceride concen- 158(7):3037–3045, 1997.
trations. J Am Coll Cardiol 9(2):263–268, 1987. 249. Lacorazza HD, Guevara Patino JA, Weksler ME, et al: Failure of rearranged TCR trans-
219. Eliasson M, Evrin PE, Lundblad D: Fibrinogen and fibrinolytic variables in relation to genes to prevent age-associated thymic involution. J Immunol 163(8):4262–4268, 1999.
anthropometry, lipids and blood pressure. The Northern Sweden Monica study. J Clin 250. Hartwig M, Steinmann G: On a causal mechanism of chronic thymic involution in
Epidemiol 47(5):513–524, 1994. man. Mech Ageing Dev 75(2):151–156, 1994.
220. Cawkwell RD: Patient’s age and the activated partial thromboplastin time test. Thromb 251. Plum J, De Smedt M, Leclercq G, et al: Interleukin-7 is a critical growth factor in early
Haemost 39(3):780–781, 1978. human T-cell development. Blood 88(11):4239–4245, 1996.
221. Bauer KA, Weiss LM, Sparrow D, et al: Aging-associated changes in indices of thrombin 252. Le PT, Kurtzberg J, Brandt SJ, et al: Human thymic epithelial cells produce granulocyte
generation and protein C activation in humans. Normative Aging Study. J Clin Invest and macrophage colony-stimulating factors. J Immunol 141(4):1211–1217, 1988.
80(6):1527–1534, 1987. 253. Le PT, Lazorick S, Whichard LP, et al: Human thymic epithelial cells produce IL-6,
222. Gurwitz JH, Avorn J, Ross-Degnan D, et al: Aging and the anticoagulant response to granulocyte-monocyte-CSF, and leukemia inhibitory factor. J Immunol 145(10):
warfarin therapy. Ann Intern Med 116(11):901–904, 1992. 3310–3315, 1990.
223. Deguchi K, Deguchi A, Wada H, Murashima S: Study of cardiovascular risk factors and 254. Le PT, Tuck DT, Dinarello CA, et al: Human thymic epithelial cells produce interleukin
hemostatic molecular markers in elderly persons. Semin Thromb Hemost 26(1):23–27, 1. J Immunol 138(8):2520–2526, 1987.
2000. 255. Gruver AL, Hudson LL, Sempowski GD: Immunosenescence of ageing. J Pathol
224. Scarabin PY, Aillaud MF, Amouyel P, et al: Associations of fibrinogen, factor VII and 211(2):144–156, 2007.
PAI-1 with baseline findings among 10,500 male participants in a prospective study of 256. Cakman I, Rohwer J, Schutz RM, et al: Dysregulation between TH1 and TH2 T cell
myocardial infarction—the PRIME Study. Prospective Epidemiological Study of Myo- subpopulations in the elderly. Mech Ageing Dev 87(3):197–209, 1996.
cardial Infarction. Thromb Haemost 80(5):749–756, 1998. 257. Hodes RJ: Aging and the immune system. Immunol Rev 160:5–8, 1997.
225. Hager K, Platt D: Fibrin degeneration product concentrations (D-dimers) in the course 258. Perussia B, Kobayashi M, Rossi ME, et al: Immune interferon enhances functional
of ageing. Gerontology 41(3):159–165, 1995. properties of human granulocytes: Role of Fc receptors and effect of lymphotoxin,
226. Tracy RP, Bovill EG, Fried LP, et al: The distribution of coagulation factors VII and VIII tumor necrosis factor, and granulocyte-macrophage colony-stimulating factor. J Immu-
and fibrinogen in adults over 65 years. Results from the Cardiovascular Health Study. nol 138(3):765–774, 1987.
Ann Epidemiol 2(4):509–519, 1992. 259. Sokolov VV, Kaplunova OA, Ovseenko TE: [Age factors in architectonics of the splenic
227. Laharrague PF, Cambus JP, Fillola G, Corberand JX: Plasma fibrinogen and physiolog- arterial vessels] [in Russian]. Morfologiia 124(4):57–60, 2003.
ical aging. Aging (Milano) 5(6):445–449, 1993. 260. Luscieti P, Hubschmid T, Cottier H, et al: Human lymph node morphology as a func-
228. Hager K, Felicetti M, Seefried G, Platt D: Fibrinogen and aging. Aging (Milano) tion of age and site. J Clin Pathol 33(5):454–461, 1980.
6(2):133–138, 1994. 261. Effros RB, Cai Z, Linton PJ: CD8 T cells and aging. Crit Rev Immunol 23(1–2):45–64,
229. Takeshita K, Yamamoto K, Ito M, et al: Increased expression of plasminogen activator 2003.
inhibitor-1 with fibrin deposition in a murine model of aging, “Klotho” mouse. Semin 262. Globerson A, Effros RB: Ageing of lymphocytes and lymphocytes in the aged. Immunol
Thromb Hemost 28(6):545–554, 2002. Today 21(10):515–521, 2000.

Kaushansky_chapter 09_p0129-0142.indd 140 17/09/15 6:16 pm